March 7, 2016 / 2:27 PM / in a year

BUZZ-Valeant Pharmaceuticals International Inc: Q4 results on March 15

** Canadian drugmaker's U.S.-listed shares up 3.6 pct at $63.35 premarket

** Says will release preliminary Q4 results March 15, followed by conference call same day

** Valeant said last week it would delay releasing results, scheduled for Feb. 29 - the day CEO Michael Pearson returned from 2-month sick leave

** It also revealed last week it was under SEC investigation

** Up to Friday's close, the U.S.-listed stock had fallen 40 pct this year

** Stock down 77 pct from a record high $263.81 hit in Aug when questions first emerged about its business and accounting practices

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below